Mapping the methodologies of Burkitt lymphoma by Clarke, B
lable at ScienceDirect
Studies in History and Philosophy of Biological and Biomedical Sciences 48 (2014) 210e217Contents lists avaiStudies in History and Philosophy of Biological and
Biomedical Sciences
journal homepage: www.elsevier .com/locate/shpscMapping the methodologies of Burkitt lymphoma
Brendan Clarke*
Department of Science and Technology Studies, University College London, Gower Street, London WC1E 6BT, UKa r t i c l e i n f o
Article history:
Available online 12 September 2014
Keywords:
Burkitt lymphoma
Big science
Cancer viruses
Geographical pathology
Long safari
Maps* Tel.: þ44 (0) 2076797132.
E-mail address: b.clarke@ucl.ac.uk.
http://dx.doi.org/10.1016/j.shpsc.2014.08.005
1369-8486/ 2014 The Author. Published by Elseviera b s t r a c t
While recent accounts have emphasised the planned, large-scale and systematic character of cancer virus
research in the mid-C20, I argue here that a distinctive kind of small-scale scientiﬁc research existed, and
made a distinctive contribution to the development of the ﬁeld as a whole. Using the case of the research
carried out to understand the causes of Burkitt lymphoma in Africa during the 1960s, I highlight two
distinctive practicesdgeographical mapping and the re-purposing of existing disease infra-
structuredthat played a central role in this episode. My intention here is threefold: ﬁrst, I will argue that
this research is unlike the research practices usually identiﬁed as typical ‘big science’ research con-
cerning cancer viruses, particularly in the United States. Second, I will argue that this kind of research is
also clearly distinct from the kind of research that Derek Price (Price, 1963) characterised as ‘little sci-
ence’. Thirdly, I will sketch a positive characterisation of this kind of research as ‘small science’. I conclude
by suggesting that this characterisation may be applied to other kinds of historical biomedical research,
and that so doing may offer the pluralist a useful alternative way of understanding medical research in
the twentieth century.
 2014 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).When citing this paper, please use the full journal title Studies in History and Philosophy of Biological and Biomedical Sciences1. Introduction
Historical interest in viruses and cancer has grown steadily
over the last few years. Perhaps this is unsurprising: cancer virus
research played a prominent role in the development of labora-
tory medicine in the twentieth century. This role of cancer virus
research within major biomedical research programmes (partic-
ularly in the USA) has been developed in work that tends to
emphasise its planned and institutional character. For example,
cancer virus research may be discussed in the context of major
planned research efforts (Gaudillière, 1998; Schefﬂer, 2014), in the
institutional interactions between biomedical research estab-
lishments and other quasi-governmental institutions, such as
prisons (Stark & Campbell, 2014), or as contributor to research in
other ﬁelds, such as molecular biology (Gaudillière, 1998). As John
Pickstone points out, this alignment of the historiography of
cancer virus research largely along institutional lines is of a pieceLtd. This is an open access article uwith other social histories of medicine, where both the form of
the work and the intensions of the historian have largely been
imported from other contexts. Particularly important in this
regard are “sociological histories of modernisation and industri-
alisation” (Pickstone, 2012: 239) which acted as important
intellectual drivers of the development of social history
of medicine in the late twentieth century (reviewed in Porter,
1995).
This is not to say that cancer virus research itself (as scientiﬁc
practice) was conﬁned to large research institutions. As the other
papers in this issue also relate, the actual practices that contrib-
uted to tumour virology research in the later twentieth century
were exceptionally polymorphous. This paper will sketch out one
group of research that does not align with the dominant narrative
of centralised science, and one that is thus not so clearly visible
through the usual historiographical optics. Its aim therefore is to
focus on research work occurring at a rather small scale. Impor-
tant too is that this work occurred outside the United States,
placing the practices reviewed here at further geographical
remove from the big medicine of (for example) the National
Cancer Institute.nder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
1 The means by which EBV causes a range of diseases depending on context is
complicated, and the technical details go far beyond the scope of this essay. In very
general terms, though, it appears to be the case that infection with EBV interacts
with other agents to promote the development of chromosomal abnormalities
(particularly translocations), and it is these that bring about malignant disease.
Unlike other tumour viruses, such as human papillomavirus, where infection with
different strains of the virus manifest as different types of cancer, the link between
EBV and human disease seems highly multifactorial, with different combinations of
virus plus other causal factors leading to different diseases. For details of these in
relation to EBV, see Thorley-Lawson & Allday (2008).
2 Some of these reports were widely disseminated. For example, there was a
clinical meeting in the Mulago hospital in Uganda in October 1955, proceedings of
which were published as a short article entitled ‘Tumours of the Jaw’ on the 29th
exists, at which Burkitt was present (Singh, 1955). In this note, the higher incidence
of jaw tumours at Mulago than in either Europe or America was noted (Singh, 1955,
70). Other reports from Uganda at the turn of the century were also known (Davies
et al., 1964; Hutt, 1981, 762).
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tumour virology, and it does this via the case of Burkitt lymphoma
(BL hence) in Equatorial Africa between 1950 and 1970. While
many historical accounts of these events have been given before
(Evans, 1993; Glemser, 1971; zur Hausen, 2006; Hutt, 1981), they
are ﬁrmly aligned with a historical tradition that Stark and
Campbell characterise as “organized searches for causes, thera-
peutics, and preventions” (2014: 218). While this paper will
discuss just such a search for causes and prevention, my emphasis
here is on the means by which these goals were sought, rather
than the details of the causes or prevention strategies that were
eventually found. I have selected two kinds of research work for
special attention. First is the group of geographical research
practices used to investigate the aetiology of BL during the 1960s.
While these have previously been described as romantic adven-
ture stories of derring-do in the tropics (Glemser, 1971), my
intention here is to understand them more in terms of the
growing interest in the history of science community of under-
standing the geography of the production of scientiﬁc knowledge.
This alternative means of describing the role of placeddescribed
as the ‘geographical turn’ in the history of science by Finnegan
(2008: 369)din part consists of a greater attention to the role
played by location in conditioning the character of scientiﬁc ac-
tivity. In this essay, I therefore aim to pick out some of the
geographical techniques employed in this case, and to demon-
strate how these techniques shaped ideas about the nature and
causation of BL.
Second, I have picked out a number of examples where existing
research infrastructuredparticularly that put in place to conduct
malaria researchdbecame reused by researchers interested in BL.
Each of these two studies is intended to reﬂect in more detail my
historiographical middle-way. In turn, this should serve as a
corrective to the prevailing historical interpretation of the search
for cancer viruses. While planned, managed, or centralised
research was an important part of the ﬁeld (see, for that, Schef-
ﬂer’s paper 2014), it was not constitutive of it. Epistemologically
and practically distinctive things happened in the intellectual
cracks and corners, and these played a key role in shaping the
much more visible big science of national institutions. Yet these
practices, which I refer to below as small science, have been poorly
served by this emphasis on centralisation, planning and
management.
The structure of this paper will be as follows. In Section 2, I give
an outline of research conducted on Burkitt lymphoma in Africa
between 1950 and 1970. I then develop two areas of this research in
more detail. The ﬁrst of these, discussed in Section 3, is the role of
maps and mapping practices, and their interactions with other
research practices, while in Section 4, I deal with the re-use of
research infrastructure to investigate this disease. I then move to
more conceptual territory in Section 5, where I characterise (in
fairly general terms) small science, and brieﬂy hold up certain as-
pects of the BL case as useful illustrations of this kind of scientiﬁc
practice.
2. Burkitt lymphoma
This case deals with research conducted between 1950 and 1970
on BL, a tumour syndrome caused by infection with EpsteineBarr
Virus (EBV). EBV has a world-wide distribution, and is associated
with the development of a range of malignant and non-malignant
conditions (Deyrup, 2008). While up to 90% of adults show evi-
dence of prior infection (Henle et al., 1969), the development of
malignant disease is rather rare in the developed world, where
infection manifests most usually as infectious mononucleosis
(glandular fever). However, in combination with environmentalfactors found in the tropics, the virus can contribute to the devel-
opment of BL, which is a highly malignant and rapidly progressive
extranodal B-cell lymphoma.1 This cancer mainly affects children,
and has a number of unusual clinical features, such as its predi-
lection for anatomical sites not usually associated with malignancy,
such as the bones of the jaws.
A very brief account of the clinical (rather than laboratory)
research performed on this disease is as follows: the strangely high
incidence of jaw tumours of atypical appearance in children was
reported several times in Equatorial East Africa during the ﬁrst half
of the twentieth century.2 These were usually regarded more as
curiosities than viable targets of research:
His face was massively swollen, with bizarre lesions involving both
sides of his upper and lower jaws. I had never seen anything like it.
The teeth were loose and the features grossly distorted. If a single
jaw quadrant had been involved, I might have considered it to be an
infective process such as osteomyelitis, but not with all four
quadrants affected. This unusual distribution also seemed to rule
out any form of neoplasia. Results of the biopsy had suggested some
form of granuloma. I was totally bafﬂed, but photographed the
child and considered this to be another of the curiosities one had to
become accustomed to seeing from time to time in Africa.
(Burkitt, 1983, 1777)
However, further encounters with other children with similar
symptoms rapidly changed the status of these curiosities. Not only
did other children havemassive, characteristic tumours in the jaws,
they also had distinctive abdominal tumours. This combination of
tumours in the jaws and at multiple sites in the abdomen arising
simultaneously suggested the operation of some altogether un-
known disease mechanism. Further research (see Burkitt, 1983;
Clarke, 2011; Hutt, 1981) revealed that, far from being occasional
oddities, cases of this tumour syndrome were alarmingly common
in Uganda. Early descriptions of the syndrome (Burkitt, 1958;
Burkitt & O’Conor, 1961; O’Conor, 1961; O’Conor & Davies, 1960)
gave clinical, epidemiological, pathological and histopathological
features. Of particular note was that the tumour syndrome was
caused by some kind of extranodal lymphoma; that the disease was
geographically conﬁned to an East-West belt across Equatorial Af-
rica; and that the incidence rate was extremely high in localised
areas within this lymphoma belt. Rather than being an isolated
oddity, it appeared instead that a very common cancer had been
hidden in plain sight. As the manifestations of the disease were not
subtledinstead ﬂorid, progressive, and fataldthe fact that so little
attention had been paid to isolated cases of the disease was
somewhat mysterious:
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nected tumours were, in fact, but different manifestations of one
tumour syndrome that initiated investigation of the problem as a
whole.”
(Burkitt, 1962d, 75e6)
It is no surprise that a discovery of a new kind of cancer would
prompt many questions. Those asked during the early stages of BL
research can be conveniently grouped into four kindsdquestions as
to the nature of the clinical condition, questions as to its aetiology,
questions concerning possible therapeutic strategies, and questions
about prevention. My focus in what follows is on the ﬁrst two of
these questions: those of the nature of the syndrome, and of its
possible causes.3 While the disease itself was an unusual one-
doccurring at unusual anatomical sites apparently simultaneously,
highly aggressive, and affecting demographic groups not
commonly afﬂicted by cancersdgiving a partial clinical description
appeared to have been neither controversial nor difﬁcult. Burkitt’s
ﬁrst publication about the disease (Burkitt, 1958) contains a
detailed description of the clinical features of this disease, including
information about demographics, geography, clinical features, his-
tology, and treatment. This was based on the description of 38 in-
dividual cases between 1951 and 1958. Throughout, each of these
cases is presented as examples of a single malignant disease: cancer
because of its histological appearance, a uniﬁed disease because of
the characteristic clinical appearance. However, despite the cer-
tainty with which these descriptions were made, much about the
syndrome remained unknown. Most importantly, as Burkitt iden-
tiﬁed “Although the clinical picture of this sarcoma is easily
recognized, its site of origin and nature remain obscure.” (Burkitt,
1958: 221).
Here, then, giving a clinical description did not require an un-
derstanding of the aetiology of the disease. Instead, this description
of clinical features appeared to pose a series of bafﬂing aetiological
problems. For example, the kinds of pathological processes
responsible for the geography of this syndrome appeared
extremely obscure. Why did this disease appear to occur almost
exclusively in central Africa?3. Maps
To see maps just as tools of communication, or as a ways of
presenting established ﬁndings, is to mistake their role in3 The relationship between these different questions is a most interesting one.
I had previously assumed that these questions would sequentially depend on one
another. Being able to give at least a partial clinical description of a disease
seemed to me to be a necessary component of understanding the aetiology of
that disease. In turn, knowing the causes of a disease seemed similarly necessary
to provide an effective treatment or prevention of it. This assumption was
mirrored by the usual answers to questions about the reasons for seeking causes
in general terms, in that causal knowledge should leave the user able to explain,
predict, and control that system (Casini, Illari, Russo, & Williamson, 2011). This
case seems to require some correction of this view of the relationship between
these different questions. As shown in Section 3, questions about the nature of
the disease continued to interact with questions about its aetiology for long
enough that this assumption should be questioned. It is also illuminating to note
that the second pair of questionsdconcerning therapy and preventionddiffer
from one another in their respective dependence on causal knowledge about
aetiology. In this case, prevention strategies certainly do seem to require some
earlier causal knowledge about aetiology, although an effective vaccine against
EBV still proves elusive (Cohen, Mocarski, Raab-Traub, Corey, & Nabel, 2013).
Therapeutic strategies, on the other hand, did not require aetiological knowledge
in the same way, and well before EBV was accepted as causing the disease, a
fairly successful treatment programme using cytotoxic agents was in place
(Clifford, 1970).permitting and shaping research. This should not be a particu-
larly shocking claim from either the historical or philosophical
side (Hess & Mendelsohn, 2010; Livingstone, 1993; Morrison &
Morgan, 1999). Rather than pushing at this open door, I will
instead tend towards the illustrative, by emphasising how the
construction and use of maps shaped research on BL. One root of
geographical research in this case is to be found in Burkitt’s bi-
ography and bibliography. An obituarist describes a “lifelong
passion for plotting things on maps” (Heaton, 1993, pp. 951). His
later work, on dietary ﬁbre and its link to diseases of
the developed world, also came, in part, from work on
geographic pathology. There too was a family connection: his
father, “an Irish surveyor and naturalist, who invented the ring-
ing of birds to plot their territories.” (Heaton, 1993, pp. 951).
Burkitt’s pre-BL research also showed an interest in working at
the intersection of the geographical and the pathological,
including geographical variation in the rates of testicular hy-
drocele (Burkitt, 1951) and subcutaneous phycomycosis (Burkitt,
Wilson, & Jelliffe, 1964).
The ﬁrst steps in BL geographical research arose at the inter-
section of two anomalous geographical features of the tumour
syndrome. First, despite being so very striking in appearance, the
disease did not seem to have been previously described. Was it the
case that this apparent failure of observation was a global phe-
nomenon, or a local one? In other words, was it the case that the
disease, occurring everywhere, had been missed everywhere?
Alternatively, perhaps the syndrome was geographically restricted
in distribution, and the omission was more local. Either result
would prompt a rather different research programme, particularly
because the identiﬁcation of geographical differences in aetio-
logical factors would presumably be a necessary part of any effort to
try and understand the causes of the condition. Early anecdotal
reports from South Africa reporting the apparent absence of the
lymphoma syndrome there seemed to suggest that the failure of
detection was indeed local, implying that some geographical cal-
culus of causes would be required. Second, very early in research,
Burkitt noticed local (i.e. within Uganda) geographical differences
in numbers of cases (Burkitt, 1983, pp. 1778e9). Again, it was not
clear which conclusions could be drawn from this ﬁnding. While
“far more cases were being referred from the northern and eastern
areas” of Uganda (Burkitt, 1983, pp.1778), it was also true that other
features of the population of these regions were capable of ac-
counting for this difference: the population density was much
higher, and transport to the University hospital in Kampala was far
easier.
Burkitt investigated these two geographical problems by
means of a postal survey, in which health workers throughout
Africa were asked to report the appearance of cases (Burkitt, 1983,
pp. 1779). Further research by literature survey and personal cor-
respondence indicated that Africa was the only region where this
tumour was found with any degree of regularity (Burkitt & Wright,
1963, pp. 69e70), although other locations where the disease
would later emergedparticularly in Western Papua New Guinea.
By mapping the medical centres from which cases had been re-
ported, Burkitt discovered that the disease was essentially
conﬁned to a sharply demarcated region of Equatorial Africa,
which became known as the lymphoma belt (Burkitt & Wright,
1963: 103e13). Once constructed, this fairly crude map was then
interrogated in some rather interesting ways to determine how
this lymphoma belt might be distinguished from its surroundings.
What here was making the difference between areas of high and
low BL incidence?
Very early in the project, it was noted that it would be possible
to account for the geographical distribution of the syndrome in
terms of climate factors (Burkitt & Wright, 1963):
Fig. 1. Route of the tumour safari. Reproduced with permission from Burkitt (1962c, p.
381).
Reprinted by permission from Macmillan Publishers Ltd on behalf of Cancer Research
UK: British Journal of Cancer. Burkitt, D. “A ‘Tumour Safari’ in East and Central Africa.”
British Journal of Cancer, 16(3): 379e86, copyright 1962.
5 It is worth clarifying the terminology at this point. Leukaemia and lymphoma
are both malignant tumours of blood cells. Lymphomas are solid tumours, while
leukaemia exists in a distributed form in the blood and bone marrow. Lymphoma
and leukaemia may also differ in the kinds of blood cell from which they originate.
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mean temperature fell below 60 degrees F. at any time of year, areas
over 5,000 feet in altitude, and areas where the mean rainfall of the
year fell below 30 inches, he could produce a map which is almost
identical with the map of tumour distribution. This suggests that
the type of vegetation (being dependent on rainfall) and the tem-
perature are two major factors determining the distribution of this
tumour.”
(Burkitt, 1961, pp. 512e3)
Finding that the syndrome was largely conﬁned to these low-
lying, warm, and wet areas, and that these conditions matched
those favoured by many disease-transmitting insects, Burkitt pro-
duced similar comparative maps which compared the distribution
of the tumour to the distribution of several prevalent arthropods
known to be disease vectors. Two of thesedtsetse (Glossina spp.),
and Anopheles mosquitoesdwere an extremely good ﬁt to the
lymphoma belt (Burkitt & Wright, 1963, pp. 131e2). In the second
case, a recent outbreak of another Anopheles-transmitted dis-
easedO’NyongeNyong feverdwith a similarly distribution
apparently limited by climate, acted as further evidence implicating
the mosquito. From these analogous cases:
Fromwhat has been found out so far about this tumour one cannot
but be impressed with the resemblance this has to some of the virus
induced tumours of mammals and cannot avoid wondering if this
might not be a virus induced tumour of African children.It would
appear that there is a prima facie case for investigating this
possibility.
(Burkitt & Davies, 1961, pp. 369)
Unfortunately the authors are not explicit at this point regarding
which virus induced tumours of mammals they mean. However,
other sources (e.g. Burkitt & Wright, 1963: 135) suggest that poly-
oma virus infections in rodents produced a superﬁcially similar
clinical syndrome (Stewart, 1955).
Regional investigations of the distribution of the disease as a
whole were matched with a programme of more local geographical
research. Three researchers (Denis Burkitt, Ted Williams and Clif-
ford Nelson), packed into a battered Ford station wagon, visited 56
medical centres across eight countries on the south-eastern tail of
the lymphoma belt during late 1961 (Burkitt, 1962c; Burkitt &
Wright, 1963, pp. 113ff). Dubbed the “tumour safari”, the inten-
tion was to visit medical units straddling the borders of the lym-
phoma belt to attempt to sharpen the lines of demarcation between
tumour-bearing regions and non-tumour bearing ones.4 Here, the
initial mapping of tumour cases was used to plan the route of the
safari, as shown in Fig. 1 (Burkitt, 1962c, pp. 381). In turn, the dis-
tribution shown on this initial map was reﬁned and corrected
during the safari by tracing cases occurring at the margins of the
belt to their originating locality, rather than to the medical centre
fromwhich they had been reported (Burkitt, 1962c, pp. 381). Other
features of the distributiondsuch as its suspected dependence on
climatic factorsdwere also investigated, by showing, for example,
that local tumour incidence appeared to vary with altitude and
minimum temperature (Burkitt, 1962c, pp. 385e6).
A more global interaction between maps and other research
methods was also in play during the early 1960s. A set of4 This unusual method was explained via a pathological analogy “This exercise
would be comparable to the pathologists choice of marginal tissue for detailed
histological examination of any lesion.” (Burkitt, 1962c, pp. 380).comparisons of incidence rates of various cancers in various con-
texts was part of early BL research. This was carried out in Uganda
from 1951 by the Kampala Cancer survey (O’Conor & Davies, 1960,
527), which collected data from cases of cancer admitted to hos-
pitals in the Ugandan capital. While difﬁculties in data inter-
pretationdsuch as uncertainty surrounding the size of the
population from which this data was collected (O’Conor & Davies,
1960, pp. 528)dthese authors attempted to draw a number of
conclusions about the kinds of childhood cancer seen in Uganda.
Most strikingly, the relative rates of both leukaemia and lymphoma
were very different in Uganda when compared to other
geographical contexts.5 Leukaemia was much more common than
lymphoma both in the developed world (O’Conor & Davies, 1960,
pp. 528e9), and in regions of Africa outside the lymphoma belt
(Higginson & Oettlé, 1960, pp. 651e3). However, this relation was
reversed: within Uganda, lymphoma much more common, andAs the name might suggest, lymphoma comes from malignant change affecting
lymphocytes or lymphocyte precursor cells. Leukaemia may originate from
lymphoid cells too, in which case the disease is called lymphoid leukaemia. Alter-
natively, leukaemia may come about from the myeloid cell lines that usually give
rise to red blood cells and non-lymphoid immune blood cells. This kind of
leukaemia is called myeloid leukaemia. For an overview of this classiﬁcation in
more detail, see Harris et al. (1999).
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world (O’Conor & Davies 1960).6 The authors noted:
Since malignant lymphoma in this study has replaced lymphatic
leukaemia as the most common neoplasm of childhood, it is sug-
gested that this may represent a true variation in the site of ma-
lignant proliferation and, more important, an alteration in the
natural history and course of the diseases of the lymphopoietic
system.
(O’Conor & Davies, 1960, pp. 529)
This suggestion was followed by others researching cancers in
Africa. For example, in a report on lymphoma in Kenya carried out
in collaboration between the Sloan-Kettering Institute in New York
and the Medical Research Laboratory in Nairobi, similar claims
were made for the reciprocal relationship between leukaemia and
lymphoma:
Study of the lymphomas of African children has led to the obser-
vation that these may well be simply a different expression of
childhood lymphoma which in North America usually manifests
itself as acute leukaemia.
(Dalldorf, 1962, pp. 1028)
In other words, this inversion of the expected ratio of
leukaemia and lymphoma cases within the belt led to the suspi-
cion that lymphoma syndrome was perhaps an unusual mani-
festation of lymphoblastic leukaemia. If this was true, and given
the interest in ﬁnding an infectious aetiology for leukaemia in the
United States (Schefﬂer, 2014), it suggested that BL too might be
caused by a virus of some kind. In concert with the other evidence,
it suggested that the syndrome might be due to an arthropod-
vectored virus (Burkitt, 1962a, 234; Burkitt, 1962b, 217e9;
Burkitt, 1962d, 77).
These very active roles played bymaps andmapping practices in
research suggest that they played an epistemic role in this pro-
gramme akin to those roles of models of scientiﬁc systems (De
Chadarevian & Hopwood, 2004; Morrison & Morgan, 1999).
Broadly, models are devices that can be used to understand target
systems by representing certain aspects of that target system. An
example of this clarifying power of representation is the map of BL
cases produced by Burkitt. Representing one aspect of
many particular cases of the diseasedtheir geographically
locationddrew out an important feature of BL as a whole. This
“partial representation” (Morrison & Morgan, 1999, p. 27) of the
disease was used as evidence when trying to understand other
aspects of BL, such as its relationship with leukaemia. These maps
were built from evidence (here, the geographical locations of each
case of BL), and then used as evidence (that the syndrome was
geographically restricted) when substantiating causal claims
regarding the aetiology of BL. This embedding of these particular
maps in the context of African BL research suggests that they ful-
ﬁlled similar roles to other kinds of models in very different
biomedical contexts, such as the chromosome maps used as
research models in Drosophila genetics (Kohler, 1994), which
similarly represented some (but not all) of what was understood
about particular chromosomal loci. These interactionsdbetween6 A total 125 microscopically conﬁrmed cases of cancer in children were reported
to the survey between 1951 and 1958. Of these, 7 were cases of leukaemia (5
myeloid, 2 lymphoid), while 60 were lymphomas. Of these, 57 were recorded as
‘lymphosarcomas’ which was the contemporary terminology for BL, while the
remaining 3 were Hodgkin’s lymphoma.maps and research, and research and mapsddiffer from the con-
ceptual claims drawn about maps in much of biogeography. For
example, in a recent book (2011, p. 5), the biogeographer Tom Koch
argues that “maps present the discrete elements of an epidemic or
pandemic occurrence.as a uniﬁed event.” While maps did serve
similar roles in this case, such as aggregating the disparate cases of
the lymphoma syndrome into a uniﬁed ‘lymphoma belt’, they
played many other roles too. Here, far from stripping away the
properties of the things plotted, in this case, new means of pro-
ducing evidence (e.g. geographical comparisons) emerged from the
production and investigation of maps. This production made
apparent phenomena that had previously remained hidden within
alternative conceptual structures of inquiry.
For some researchers involved in this project, the development
of these mapping practices themselves was to remain a focus of
inquiry. Burkitt, for example, continued to research both the
geographical aspects of particular diseases (for instance, work on
dietary ﬁbre and bowel disease in Burkitt, Walker, & Painter,
1972), and the conceptual features of disease geography. This
included work on the role of geographical studies in malignant
diseases in general (Burkitt, 1965); the role of comparative
geographical studies of disease (Burkitt, 1969, 1970) in under-
standing disease causation; the special role played by geograph-
ical methods in investigating disease peculiar to particular tribal
groups (Burkitt, 1969); and the role played by mapping in un-
derstanding disease outbreaks that cross national borders
(Burkitt, 1968).
4. Mosquitoes
A second evidential feature of this case developed through the
reuse of existing research infrastructure. While several different
examples of this are to be found in the literature, by far the most
common was the re-purposing of tools and techniques intended to
investigate and control malaria, a disease of major public health
importance in the contexts where Burkitt lymphoma was found.
For example, as malaria is transmitted by Anopheles mosquitoes,
regular counts of these insects were performed in many districts,
in part to gauge the impact of mosquito-suppression measures.
This work on the vector (the mosquito) was matched to a sur-
veillance programme on the disease itself. This had two wings:
surveillance of malaria incidence (see also MARA (2010), a
contemporary continuation of these African malaria surveillance
programmes) and the use of opportunistic or diagnostic exami-
nations of blood ﬁlms, used to detect malaria parasites directly in
individuals.
As the geographical distribution of the disease suggested that an
insect vector of some kind might play a role in transmitting it, the
collection of arthropods as part of the surveillance of insect-borne
diseases played a critical evidential role in supporting particular
claims regarding the aetiology of BL. Not least, the maps of insect
distributions that resulted from this provided maps, useful when
trying to understand the possible causes of the belt-like distribu-
tion of BL (as discussed in Section 3).
Similarly, blood ﬁlms were extensively re-purposed to demon-
strate important clinical features of the tumour syndrome. As
blood-ﬁlms for malaria would also effectively detect the abnormal
blood cells found in leukaemia, this acted as a kind of unintentional
surveillance programme, which showed that the incidence of
leukaemia was very much lower than expected throughout the
lymphoma belt. Incidence rates of lymphoma were also re-used
from other research work, with the two main sources being the
Mulago hospital pathology records (and collated during research
into malignant diseases of the heart by Lothe and Somers, 1960)
and the Kampala Cancer Survey (Davies, Wilson, & Knowelden,
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tion on the rates of different cancers occurring in the area of
Mulago, together with comparative incidence data for the devel-
oped world. The conclusion of this was that malignant lymphoma
was very much more common (by a factor of nearly four times
(Lothe & Somers, 1960, pp. 160)) in Uganda than Europe. When this
was combined with other data showing the high incidence of
lymphomas, this inversion of the usual rates of lymphoma and
leukaemia was a key piece of evidence in support of claims that a
virus might cause the condition, with the further suggestion that
some kind of common aetiologymight be shared by this lymphoma
syndrome and leukaemia, with distinct environmental factors in
different geographical contexts leading to the development of one
or the other.
There are many other details of this case to relate (see Clarke,
2011, pp. 25e52). Very brieﬂy, however, the main events are as
follows. Many different vectored viruses were suggested as
possible causes of the tumour syndrome (reviewed in Epstein,
Henle, Achong, & Barr, 1965), mainly because they were occa-
sionally detected in biopsied tumour material. However, the
accidental ﬁnding that BL cells could survive in cell culture
(Epstein & Barr, 1964) lead to the detection of EBV viral particles by
electron microscopy within cultured BL cells in early 1964
(Epstein, Achong, & Barr, 1964). Further characterisation of this
virus led to the suspicion that it was aetiologically involved, not
just in BL, but in a range of cancers (Henle & Henle, 1966a, 1966b).
As regards BL speciﬁcally, it was generally accepted as being
caused by EBV infection until the completion in 1978 of a pro-
spective study involving 42 000 children in the African lymphoma
belt, which showed qualitative and quantitative differences in the
immune response to EBV between affected and non-affected in-
dividuals (De-Thé et al., 1978).7 The Wombles were a race of ﬁctional, furry, anthropomorphic creatures who
subsisted by recycling the human detritus that they discovered on Wimbledon
Common in South London. They ﬁrst appeared in a series of children’s books
(Beresford, 2010, for example), but came to widespread prominence via a hugely
popular series of television programmes for children that began broadcasting in the
mid-1970s. Their mottod“Make Good Use of Bad Rubbish”dseem highly apt in
describing the practices of small science.5. Little, small, and big sciences
Derek Price’s 1963 book gave rise to what is now a venerable
distinction between big and little science. However, each side of
the distinction did not receive equal attention: Price’s emphasis
was ﬁrmly on the characteristics and implications of big science,
with little science as little more than a contrast-class of methods
and practices. While Price deprecating the traditional picture of
“.the Little Scientist as the lone, long-haired genius, moldering in
an attic or basement workshop, despised by society as a
nonconformist, existing in a state of near poverty, motivated by
the ﬂame burning within him?” (Price, 1963, pp. 3), he did little to
explicitly correct it, beyond some rather vague claims about the
way in which little science was the antecedent of big science. This
characterisation of little science, then, was primarily a negative
one: little science as whatever big science was not. And big sci-
ence, while a big idea, is itself a slender concept: science grows
exponentially, in a logistic fashion, towards a culturally-
determined saturation point. This saturation has three major im-
plications. First, it erodes the average quality of scientiﬁc work (as
more training of scientists means an increase in the recruitment of
those notdfor one reason or anotherdbest suited to excel). Sec-
ond, it leads to an explosion of scientiﬁc publications. Third, the
cost of doing science increases dramatically. In turn, these difﬁ-
culties drive the centralisation of science: large research in-
stitutions solve problems of cost; a rise in the number of authors
of an average research article (Price, 1963, pp. 87e90) and the
development of highly cited journals to obviate the problem of
undesirably low signal-to-noise ratios caused by high volume, low
average quality scientiﬁc publication; the generation of invisible
colleges to avoid the journals altogether:“In many ways the modern ease of transportation and the afﬂuence
of the elite scientist have replaced what used to be effected by the
publication of papers. We tend now to communicate person to
person instead of paper to paper. In the most active areas we diffuse
knowledge through collaboration. Through select groups we seek
prestige and the recognition of ourselves by our peers as approved
and worthy collaborating colleagues.”
(Price, 1963, pp. 90e1)
To analyse by contrast, then, little science will consist of few
activities, performed by the few: an elite of highly motivated, and
highly skilled, actors. Little science will be relatively inexpensive
(certainly when compared to the integer-percentage-of-GDP ap-
petites of big science). These actors will not work in large in-
stitutions, but small ones. Communication within this sparse
community will be via a small number of scientiﬁc journals without
evidence of the super-specialisation that is a feature of the viable
big science journal. Finally, big science was (in the early 1960s)
new: “a change in the state of science the like of which we have not
seen for 300 years.” (Price, 1963, pp. 115).
While I stress that this characterisation is a result of my own
contrastive working through of Price on big science, it seems a fair
ﬁt to the historical cases that he invokes to illustrate the workings
of little science. That, to me, seems sufﬁcient for my purposes,
which are to suggest that Price’s distinction between big and little
science is just a distinction between two kinds of scientiﬁc practice,
rather than an exclusive and exhaustive dichotomy. My argument
here follows a suggestion of Price’s:
“.tucked away in some academic corners, modern Big Science
probably contains shoestring operations by unknown pioneers
who are starting lines of research that will be of decisive interest
by 1975.”
(Price, 1963, pp. 3)
Now even given Price’s rather anaemic characterisation of little
science, this activity in the gaps of big science does not appear to
refer to little science. Broadly, if little science is the parent of big
science, this kind of scientiﬁc built into the corners of big science
research is something different, a Womble-ish contemporary.7 For
the sake of convenience, I have termed this small science, and my
aim over the remainder of this section is to sketch a characterisa-
tion of this small science in general terms, and to give illustrative
vignettes drawn from the BL case given above.
As a ﬁrst point of contrast, Price argues that there is an ancestral
relationship between little and big science. But while little science
evolved into big science, small science is contemporary with, and
complimentary to, big science. In the BL case, the claim of non-
antecedence can be easily drawn. There was big science human
cancer virus research happening at the same time as this small
science, such as the Special Virus Cancer Program. In this case,
though, the small science discussed here did not lead directly to big
science research. Rather than the ancestor, small science is the
contemporary of big science here. Neither should small science be
regarded as some kind of primitive counterpart to big science.
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reuse of data collected from malaria and cancer research projects.
Next, these kinds of scientiﬁc practice can be distinguished by a
differing approach to their phenomena of interest. The questions
addressed by small science research aim to make sense of poorly-
characterised phenomena. Here, the aim is to investigate features
of the world that are poorly characterised or understood via wide-
ranging and omnivorous programmes of research. Neither the
problem, the necessary methods, nor the kinds of answers pro-
duced, will be known or understood at the outset of research. This
kind of uncertainty can be contrasted with the (deceptive) certainty
of strategies found in big-science. Here, the aims, paths and ob-
jectives of research are ostensibly well-understood before research
begins. This lends a veneer of certainty regarding the phenomena in
question, the methods used to research it, and the kinds of answers
thrown up by this research, which is quite lacking in small science.
The interaction between descriptive and aetiological questions in
geographical research in the BL case is the salient example here: the
description of the disease (its distribution, for example) changed,
and was changed by, descriptions of possible aetiological factors
(such as arthropod distributions).
These different aims, paths, and objectives of big science and
small science give rise to a distinctive set of social, cultural, and
epistemological values for each. These values are so ingrained
into the research that small science research projects require
profound translation before they can participate in the systematic
and grand work found in big science. As a consequence of the
uncertainty that so visibly surrounds them; the conclusions of
small science research projects are often highly equivocal. These
doubt-full and nuanced ﬁndings require translation or re-working
before they can participate as targets or tools of inquiry in the
decidedly more certain context of big science. This barrier of
translation promotes the autonomous coexistence of small sci-
ence in a landscape dominated by big science. While little science
may be the ancestor of big science, small science projects do not
grow up to become big science. They are not ﬁrst steps, but in-
dependent research programmes in their own right. That is not to
say that big and small sciences are isolated from one another.
Instead, they are joined by networks of reciprocal connections
that operate through a permeable membrane of values. For
example, ideas or practices that have arisen in the sphere of big
science may well circulate into, and inﬂuence, small science
research, and vice versa.
My central, rather broad metaphor here is one of pollination
occurring between big science and small science. In the BL case,
there were several reciprocal interactions with big science-type
projects, such as later prospective epidemiological and virological
research. For instance, BL researchers in Africa passed much clinical
and epidemiological material to laboratories in the developed
world, and this material participated in virological (Epstein et al.,
1964), serological (Henle & Henle, 1966a, 1966b) and epidemio-
logical research (De-Thé et al., 1978). In turn, these researchers have
led to BL and EBV being used as model systems in much other
cancer virus research in the later twentieth century (Bouffet,
Frappaz, Pinkerton, Favrot, & Philip, 1991).
6. Conclusion
To conclude, I suggest that the BL case does not ﬁt neatly into
Price’s dichotomous classiﬁcation of big and little science, but
instead shares features of each. For want of a better term, I have
characterised this kind of scientiﬁc practice as small science. As
regards this quibbling with Price, my intention is modest: I have
argued above that big and little science should be regarded as a
reasonable way of characterising some, but not all, kinds of cancervirus research in the twentieth century. In other words, I suggest
that Price’s characterisation should not be interpreted as an
exhaustive dichotomy. With reference to the particular case of
cancer virus research discussed in detail here, characterising kinds
of scientiﬁc practice in this more pluralistic way is worthwhile:
there is much that is historically interesting in cancer virus research
that does not ﬁt neatly into a historiography dominated by cen-
tralised research. I argue that rather different messages emerge
when the diverse parts of the BL storydbig and smalldare
aggregated: as is so often the case, the sense of the whole is at
variance with the senses of its constituent parts. If any more broad
lesson is to be extracted from this aggregationdbeyond the simple-
minded one that a problem centred in our sights tends to look
rather different from one glimpses in our peripheral visiondis
should be this: not all fruitful work on viruses and cancer was
planned, managed, or centralised.
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